Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
This is a PET/CT study using the 18F-αvβ6-binding-peptide.The goal of this study is to evaluate this peptide in patients after infection with SARS CoV2.
Description: Completion of administration of 18F-αvβ6-BP in SARC CoV2 patients
Measure: Administration of 18F-αvβ6-BP Time: baselineDescription: Completion of administration of 18F-αvβ6-BP in SARC CoV2 patients
Measure: Administration of 18F-αvβ6-BP Time: 3 monthsDescription: Completion of administration of 18F-αvβ6-BP in SARC CoV2 patients
Measure: Administration of 18F-αvβ6-BP Time: 6 monthsDescription: Uptake of 18F-αvβ6-BP in lung damage will be measured by PET
Measure: Determine whether 18F-αvβ6-BP demonstrates accumulation in lung damage Time: baselineDescription: Uptake of 18F-αvβ6-BP in lung damage will be measured by PET
Measure: Determine whether 18F-αvβ6-BP demonstrates accumulation in lung damage Time: 3 monthsDescription: Uptake of 18F-αvβ6-BP in lung damage will be measured by PET
Measure: Determine whether 18F-αvβ6-BP demonstrates accumulation in lung damage Time: 6 monthsDescription: Uptake of 18F-αvβ6-BP in lung measured by PET will be compared to lung damage as indicated on CT.
Measure: Determine whether 18F-αvβ6-BP accumulation in lung correlates to lung damage as indicated on CT. Time: baselineDescription: Uptake of 18F-αvβ6-BP in lung measured by PET will be compared to lung damage as indicated on CT.
Measure: Determine whether 18F-αvβ6-BP accumulation in lung correlates to lung damage as indicated on CT. Time: 3 monthsDescription: Uptake of 18F-αvβ6-BP in lung measured by PET will be compared to lung damage as indicated on CT.
Measure: Determine whether 18F-αvβ6-BP accumulation in lung correlates to lung damage as indicated on CT. Time: 6 monthsAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports